BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17503475)

  • 1. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample.
    Piccardi M; Congiu D; Squassina A; Manconi F; Putzu PF; Mereu RM; Chillotti C; Del Zompo M
    Am J Med Genet B Neuropsychiatr Genet; 2007 Oct; 144B(7):895-9. PubMed ID: 17503475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine.
    Scacchi R; Gambina G; Moretto G; Corbo RM
    Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):502-7. PubMed ID: 18780301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B
    Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study.
    Cook LJ; Ho LW; Wang L; Terrenoire E; Brayne C; Evans JG; Xuereb J; Cairns NJ; Turic D; Hollingworth P; Moore PJ; Jehu L; Archer N; Walter S; Foy C; Edmondson A; Powell J; Lovestone S; Williams J; Rubinsztein DC
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jan; 132B(1):5-8. PubMed ID: 15690550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
    Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
    Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease.
    Harold D; Macgregor S; Patterson CE; Hollingworth P; Moore P; Owen MJ; Williams J; O'Donovan M; Passmore P; McIlroy S; Jones L
    Pharmacogenet Genomics; 2006 Feb; 16(2):75-7. PubMed ID: 16424819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Ki CS; Na DL; Kim JW; Kim HJ; Kim DK; Yoon BK
    Am J Med Genet; 1999 Apr; 88(2):113-5. PubMed ID: 10206226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4.
    Kim KW; Suh YJ; Park WY; Jhoo JH; Lee DY; Youn JC; Lee KH; Seo JS; Woo JI
    Neurosci Lett; 2004 Aug; 366(2):182-6. PubMed ID: 15276243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease.
    Ahn Jo S; Ahn K; Kim JH; Kang BH; Kim E; Jo I; Kim DK
    Clin Chim Acta; 2006 Jun; 368(1-2):179-82. PubMed ID: 16480703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.
    Mattila KM; Rinne JO; Röyttä M; Laippala P; Pietilä T; Kalimo H; Koivula T; Frey H; Lehtimäki T
    J Med Genet; 2000 Oct; 37(10):766-70. PubMed ID: 11015454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.
    Wiebusch H; Poirier J; Sévigny P; Schappert K
    Hum Genet; 1999 Feb; 104(2):158-63. PubMed ID: 10190327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease.
    Ozturk A; DeKosky ST; Kamboh MI
    Neurobiol Aging; 2006 Oct; 27(10):1440-4. PubMed ID: 16223550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could
    Jasiecki J; Wasąg B
    Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31601022
    [No Abstract]   [Full Text] [Related]  

  • 17. Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
    Wang Z; Jiang Y; Wang X; Du Y; Xiao D; Deng Y; Wang J
    Med Sci Monit; 2015 May; 21():1408-13. PubMed ID: 25978873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease.
    Corey-Bloom J; Tiraboschi P; Hansen LA; Alford M; Schoos B; Sabbagh MN; Masliah E; Thal LJ
    Neurology; 2000 Jan; 54(2):403-6. PubMed ID: 10668702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway.
    Vijayaraghavan S; Karami A; Aeinehband S; Behbahani H; Grandien A; Nilsson B; Ekdahl KN; Lindblom RP; Piehl F; Darreh-Shori T
    PLoS One; 2013; 8(6):e65936. PubMed ID: 23840379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.